NeuroPace (NPCE) Balance Sheet: Assets & Liabilities

NeuroPace (NPCE) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), NeuroPace reported total assets of $105.56M and total liabilities of $86.53M. Shareholders' equity was $19.03M, up 137.5% from $8.01M a year earlier. Total debt stood at $70.84M against $61.06M in cash and short-term investments, a net debt position of $9.78M. That puts debt-to-equity at 3.72, compared with 7.66 a year earlier.

NeuroPace Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for NeuroPace, Inc. (NPCE) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	21.69	13.43	18.06	6.61	19.19	26.39	4.12
Short-Term Investments	39.37	39.33	48.40	70.80	96.40	11.69	0.97
Cash & Short-Term Investments	61.06	52.76	66.45	77.41	115.58	38.08	5.09
Accounts Receivable	14.68	12.85	12.31	7.48	7.09	8.40	6.02
Inventory	16.90	13.38	11.21	9.71	7.82	6.91	7.90
Other Current Assets	1.44	2.35	2.74	3.11	2.32	1.18	1.25
Total Current Assets	94.07	81.34	92.72	97.71	132.82	54.56	20.26
Non-Current Assets
Property, Plant & Equipment (Net)	11.26	12.90	14.41	15.90	0.60	0.52	0.81
Other Non-Current Assets	0.24	0.41	0.52	0.49	0.14	0.39	0.03
Total Non-Current Assets	11.49	13.31	14.93	16.39	0.75	1.39	0.84
Total Assets	105.57	94.65	107.65	114.11	133.56	55.95	21.10
Current Liabilities
Accounts Payable	2.22	2.95	2.33	2.15	1.38	0.95	0.90
Short-Term Debt	2.12	1.86	1.63	1.42	0.00	2.04	62.80
Accrued Liabilities	13.34	9.79	11.18	7.41	7.43	5.94	-
Deferred Revenue	0.14	0.56	1.09	0.00	0.00	0.00	6.73
Other Current Liabilities	13.34	9.79	11.18	7.41	7.92	0.67	4.72
Total Current Liabilities	17.81	15.16	16.23	10.98	9.30	9.60	75.15
Non-Current Liabilities
Long-Term Debt	68.72	59.53	70.77	68.35	49.85	50.82	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.91	1.58	75.30
Total Non-Current Liabilities	68.72	71.48	70.77	68.35	50.76	194.19	75.30
Total Liabilities	86.53	86.63	87.00	79.33	60.06	61.99	150.45
Stockholders' Equity
Common Stock	0.03	0.03	0.03	0.03	0.02	0.00	0.00
Retained Earnings	-552.42	-530.95	-503.81	-470.85	-423.77	-387.69	-363.64
Accumulated Other Comprehensive Income	0.00	0.00	0.00	-1.11	-0.27	0.03	0.00
Additional Paid-in Capital	571.41	538.93	524.44	506.71	497.52	239.83	160.72
Shares Outstanding	33.57	30.15	27.82	25.05	24.45	-	-
Total Stockholders' Equity	19.03	8.01	20.65	34.78	73.50	-6.04	-129.35
Total Liabilities & Equity	105.57	94.65	107.65	114.11	133.56	55.95	21.10

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About NeuroPace Balance Sheet

How much debt does NeuroPace have?

NeuroPace had total debt of $70.84M as of Dec 31, 2025, against $61.06M in cash and short-term investments. Its debt-to-equity ratio was 3.72. Total debt was $61.38M a year earlier.

What are NeuroPace's total assets?

NeuroPace reported total assets of $105.56M as of Dec 31, 2025, up 11.5% from $94.65M a year earlier. Total liabilities were $86.53M.

What is NeuroPace's shareholders' equity?

NeuroPace's shareholders' equity was $19.03M as of Dec 31, 2025, or about $0.57 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition